Abstract
We report the synthesis, characteristics, and biological evaluations of a novel theranostic agent, P14, for both in vitro and in vivo imaging of central Aβ plaques, inhibition of Aβ aggregation, and neuronal damage as well as behavioral deficits.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have